A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Clinical trial NCT02080078 · TERMINATED

Trial details

NCT number: NCT02080078
Sponsor: AHS Cancer Control Alberta
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Advanced Solid Malignancies

Start date: 2014-09-01
Primary completion: 2019-03-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.